Barobag Suspension

Generic name:barium sulfate
Dosage form: suspension
Drug class:Non-iodinated contrast media

Medically reviewed by Drugs.com. Last updated on Jul 22, 2021.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Barobag Suspension Description

Barobag is a complete 3 liter enema kit containing a barium sulfate formulation for aqueous suspension and use in filled colon examinations. The contrast medium contains approximately 97% w/w barium sulfate USP, suspending agents, dispersing agents, and simethicone. Barium sulfate has the empirical formula of BaSO4.

Barobag Suspension - Clinical Pharmacology

Barium sulfate is an insoluble material which, because of its density, provides a positive contrast during x-ray examination. Barium sulfate is an inert radiopaque material which is not absorbed or metabolized and is eliminated intact from the body in a manner similar to other non-absorbed inorganic materials. Excretion rate is a function of gastrointestinal transit time.

Indications and Usage for Barobag Suspension

Barobag is indicated for use as a contrast medium in filled colon examinations.

Contraindications

Barium sulfate products are contraindicated in patients with known or suspected obstruction of the colon, known or suspected gastrointestinal tract perforation, inflammation or neoplastic lesions of the rectum, recent rectal biopsy or known hypersensitivity to barium sulfate formulation.

Known hypersensitivity or allergy to latex is a contraindication for the use of balloon retention enema tips containing latex. The use of a retention cuff enema tip is not necessary or desirable in patients with normal sphincter tone. The presence of adequate sphincter tone can be judged by preliminary rectal digital examination.

Warnings

Serious adverse reactions, including death, have been reported with the administration of barium sulfate formulations and are usually associated with the technique of administration, the underlying pathological condition and/or patient hypersensitivities.

Barium sulfate preparations used as radiopaque media.